From spreadtrader's buddy Louis Navellier. I'm sure some of you can name these 3 stocks right off the top of your head.

1) A company that is CASHING IN big-time on the drive to cut costs in health care by filling the prescriptions for 50 million Americans! Just as drug makers have seen strong recession-proof sales, this company has also been able to stay hugely profitable, even during the worst recession in 80 years, by providing patients with the medications they want at a price they can afford.

What I like about this company is that everyone wants to use their services—individual purchasers, hospitals, insurance companies, you name it. They are doing precisely what the Obama administration says it wants to achieve with its health care reform—getting better health care for less money—but it’s doing it right now. That’s one reason why the value of the stock has nearly DOUBLED in the past seven months—and why I expect continued double-digit growth in the coming months.

2) One of the world’s fastest-growing, most successful pharmaceutical companies with $21 billion in annual sales! This company has its share of blockbuster drugs—mostly cardiovascular medications that fight high blood pressure and high cholesterol. On top of that, it makes popular antidepressants and infant formula. Americans quite literally can’t live without products like these!

Recent earnings indicate that cost-cutting measures have been extremely effective, and this company is now picking up speed again. And the planned acquisition of a big biotech firm will provide this company with even more punch, so now’s the time to buy!

3) The leading provider of diagnostic testing services in the U.S. with annual sales topping $7 billion and quarterly revenue growth of an eye-popping 73%! With over 2,000 patient service centers across the country, this company offers a wide array of tests and services—from pre-employment drug screens to complex MRIs. If your physician decides a patient needs to undergo some testing, there’s a very good chance he will refer them to one of this company’s facilities to get it done.

In the second quarter, the company reported a 17% profit increase thanks to a jump in testing revenue. When you consider how badly some companies were doing at the time, that’s proof that this is a solid, hugely profitable company. Look for a 25%-35% gain in this stock in short order.

Post edited 10:21 pm – November 24, 2009 by dlst

#2 could be Bristol-Meyers Squibb (BMY), based on a revenue match. (http://finance.yahoo.com/q/ks?s=BMY)

#3could be Quest Diagnostics (DGX) (http://finance.yahoo.com/q/ks?s=DGX). Sales fig. matches, as does rev. growth.

Oh–just noticed it was a Louis tease, in which case #1 could be Express Scripts (ESRX) since he has teased it before. March low was about 45 bucks, so that’s approx. a double.

Aaaack! 50M customers mentioned here: http://www.idtheftquiz.org/blo…..tims-list/